Agile Therapeutics Inc IPO year
What is the IPO year of Agile Therapeutics Inc?
The IPO year of Agile Therapeutics Inc is 2014
What is the definition of IPO year?
Initial public offering is a type of public offering in which shares of a company usually are sold to institutional investors that in turn, sell to the general public, on a securities exchange, for the first time.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
IPO year of companies in the Health Care sector on NASDAQ compared to Agile Therapeutics Inc
What does Agile Therapeutics Inc do?
agile therapeutics is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today's women. our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. our lead product candidate, twirla®, (ethinyl estradiol and levonorgestrel transdermal system), also known as ag200-15, is a once-weekly prescription contraceptive patch that recently completed phase 3 trials. twirla is based on our proprietary transdermal patch technology, called skinfusion®, which is designed to provide advantages over currently available patches and is intended to optimize patch adhesion and patient wearability. for more information, please visit the company website at www.agiletherapeutics.com. connect with us on twitter at @agilether.
Companies with ipo year similar to Agile Therapeutics Inc
- Australian REIT Income Fund has IPO year of 2013
- Brookfield Asset Management PRF SH CL A SE37 has IPO year of 2013
- Modern Meat has IPO year of 2013
- Blue Capital Reinsurance Ltd has IPO year of 2013
- Siyata Mobile has IPO year of 2013
- Mirati Therapeutics Inc has IPO year of 2013
- Agile Therapeutics Inc has IPO year of 2014
- Glaukos has IPO year of 2015
- UBS ETFs Public - MSCI ACWI SF UCITS ETF has IPO year of 2015
- Acasta Enterprises has IPO year of 2015
- Faron Pharmaceuticals Oy has IPO year of 2015
- GreenPower Motor Co has IPO year of 2015
- Sunrun Inc has IPO year of 2015